Quick Answer
Clearmind Medicine Inc. reported Total Assets of $6.08 million for fiscal year 2025.
Clearmind Medicine Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | $6.08M -16.2% |
$7.26M +21.9% |
$5.95M +620.4% |
$826.4K -84.0% |
$5.16M |
| R&D Expense | $2.06M +48.7% |
$1.38M -10.5% |
$1.54M -49.9% |
$3.08M +550.5% |
$473.7K |
- Clearmind Medicine Inc. reported Total Assets of $6.08 million for fiscal year 2025.
- Clearmind Medicine Inc. showed a decrease of -16.2% in Total Assets compared to the prior fiscal year.
- Clearmind Medicine Inc. reported R&D Expense of $2.06 million for fiscal year 2025.
- Clearmind Medicine Inc. showed an increase of +48.7% in R&D Expense compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: